RBC cuts Ionis Pharmaceuticals target price to $60 from $85
IONS•RBC cut its target price for Ionis Pharmaceuticals to $60 from $85.
Related News
Australia's Qantas to axe 850 jobs in offshoring deal with Accenture
ACN•
What we know about Megaspeed, Singapore-based customer of Nvidia
NVDA•
Peabody Energy Corp: Jefferies cuts to hold from buy; cuts target price to $18 from $30
BTU•
KeyBanc cuts Somnigroup International target price to $100 from $105
SGI•
Guardant Health, Inc.: Piper Sandler cuts target price to $190 from $193
GH•